Detalhe da pesquisa
1.
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 535-552, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142374
2.
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
N Engl J Med
; 374(25): 2419-29, 2016 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27332902
3.
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
Br J Haematol
; 181(4): 555-559, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28342183
4.
Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation.
Transfusion
; 50(2): 334-9, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19874563
5.
Combination chemotherapy with cyclophosphamide, thalidomide and dexamethasone for patients with refractory, newly diagnosed or relapsed myeloma.
Haematologica
; 91(6): 862-3, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16769594